Aziz Kabeer's Form 4 filing
AN2 Therapeutics, Inc. (ANTX) · filed Nov 16, 2023
- Accession no.
- 0000950170-23-064609
- Filed
- Nov 16, 2023
- Trade date
- Nov 14, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $29.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Aziz KabeerCIK 0001914847 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2023 | Common Stock | SSaleDisposed | −1,522 | $16.15 | −$24,580.3 | 2,080,051 | Indirect | |
| Nov 14, 2023 | Common Stock | SSaleDisposed | −288 | $16.15 | −$4,651.2 | 393,449 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.